Medical Patent News

RSS

European Patent Office announces intention to grant patent for Phyton Biotech's methods of producing taxanes

Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel.

13 Oct 2009

BIO disagrees with recommendations of the draft report on Gene Patenting and Licensing

The Biotechnology Industry Organization (BIO) provided comments yesterday to the Secretary’s Advisory Committee on Genetics, Health and Society regarding its draft report on Gene Patenting and Licensing and Their Impact on Patient Access to Genetic Tests. The report makes several recommendations that would restrict the ability to obtain or undermine the enforceability of patents and exclusive licenses with respect to genetic tests.

12 Oct 2009

Cook Medical files lawsuit against Endologix for patent infringement

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, acknowledged today that it has become aware that Cook Medical has filed a lawsuit against Endologix in the United States District Court alleging that Endologix infringes two of Cook's U.S. patents.

9 Oct 2009

GSK and USPTO file joint motion to dismiss litigation over final regulations

GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office).

9 Oct 2009

Cook claims infringement of its endovascular stent-grafts patents, sues Endologix

In a move aimed at protecting its worldwide market-leading technology for endovascular repair of aortic aneurysms (EVAR), Cook Incorporated has filed a complaint with the U.S. District Court, Southern District of Indiana, against Endologix, Inc. claiming infringement of two critical patents for endovascular stent-grafts.

9 Oct 2009

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

Valensa International (Orlando, FL USA) announced today that it has initiated a broad out licensing effort for University of Illinois patent (US 5,527,533 and its foreign equivalents) for the use of the astaxanthin in eye healthcare dietary supplement applications.

8 Oct 2009

Spectrascience receives Japanese patent for its Optical Biopsy Forceps System and Method of Sampling Tissue

SpectraScience, Inc., a San Diego based medical device company, today announced that it has been awarded Japanese Patent number 4361683 for its Optical Biopsy Forceps System and Method of Sampling Tissue.

8 Oct 2009

Kylin Therapeutics receives notice of allowance for its first U.S. patent application

Officials of Kylin Therapeutics Inc., a leading RNAi company, announced that they have received a notice of allowance from the U.S. Patent and Trademark Office for its first U.S. patent application.

8 Oct 2009

AGA Medical's patent on occlusion devices upheld

AGA Medical Holdings, Inc. today announced that a five-judge panel in the German Federal Patent Court in Munich has upheld the validity of an important AGA Medical patent. The court rejected a lawsuit brought by Occlutech GmbH that contended that AGA Medical's patent did not meet the standards of patentability under German law.

8 Oct 2009

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

AVANIR Pharmaceuticals, Inc. today announced that it has received a “Notice of Allowance” from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia™ well into 2025.

8 Oct 2009

Impax Laboratories settles FLOMAX litigation, to launch generic tamsulosin hydrochloride product

Impax Laboratories, Inc. today announced that it has reached agreement with Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. to settle pending U.S. litigation with regard to US Patent No. 4,703,063 for FLOMAX® (generic name: tamsulosin hydrochloride) capsules through the entry of a consent judgment confirming the validity and infringement of the patent. FLOMAX® is a treatment for the functional symptoms of benign prostatic hyperplasia.

7 Oct 2009

EnWave files a patent application for nutraREV equipment in Canada

EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.

7 Oct 2009

Vivaldi receives US patent for live attenuated influenza vaccines

Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.

6 Oct 2009

Conceptus obtains Ovion intellectual property rights from American Medical Systems

Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.

6 Oct 2009

MSF calls on drug companies to pool HIV patents

Medecins Sans Frontieres (MSF) recently launched an e-mail campaign calling on nine of the world's largest pharmaceutical companies to "release their patents on specific HIV drugs into a collective pool that will increase access and affordability to treatment in developing countries," Inter Press Service reports (Borde, 10/1).

5 Oct 2009

PrimeraDx receives its fourth patent

PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has received its fourth patent. The patent, entitled “Methods and systems for dynamic gene expression profiling”, with inventor Vladimir Slepnev, Ph.D., describes a novel method of quantitative analysis of gene expression allowing simultaneous interrogation of multiple genes in a single tube reaction.

5 Oct 2009

Caraco closes Asset Purchase Agreement with Forest as part of ANDA patent litigation settlement

Caraco Pharmaceutical Laboratories, Ltd. announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement ("APA") transaction with Forest Laboratories, Inc. ("Forest") to acquire several products from Forest's Inwood line of business.

3 Oct 2009

RXi receives USPTO notices of allowance for certain siRNA sequence-specific patent applications

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).

From Thermo Fisher Scientific Inc. 3 Oct 2009

USPTO grants Micardia's patent concerning reshaping the anatomy of the heart

MiCardia® today announced that The United States Patent Office granted patent number US7,594,887 B2, "Shape Memory Devices and Methods for Reshaping Heart Anatomy," on September 29th, 2009.

3 Oct 2009

SIS files a patent aplication for a method of generating structured light for 3D image rendering

Spatial Integrated Systems, Inc. ("SIS"), a leader in the development and integration of solutions incorporating next-generation digital 3D data capture and processing technologies, announced today that a United States patent application has been published for "system and method for generating structured light for 3-dimensional image rendering" under Publication No. US2009/0169095A1.

3 Oct 2009

Medical Patent News

European Patent Office announces intention to grant patent for Phyton Biotech's methods of producing taxanes

BIO disagrees with recommendations of the draft report on Gene Patenting and Licensing

Cook Medical files lawsuit against Endologix for patent infringement

GSK and USPTO file joint motion to dismiss litigation over final regulations

Cook claims infringement of its endovascular stent-grafts patents, sues Endologix

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

Spectrascience receives Japanese patent for its Optical Biopsy Forceps System and Method of Sampling Tissue

Kylin Therapeutics receives notice of allowance for its first U.S. patent application

AGA Medical's patent on occlusion devices upheld

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

Impax Laboratories settles FLOMAX litigation, to launch generic tamsulosin hydrochloride product

EnWave files a patent application for nutraREV equipment in Canada

Vivaldi receives US patent for live attenuated influenza vaccines

Conceptus obtains Ovion intellectual property rights from American Medical Systems

MSF calls on drug companies to pool HIV patents

PrimeraDx receives its fourth patent

Caraco closes Asset Purchase Agreement with Forest as part of ANDA patent litigation settlement

RXi receives USPTO notices of allowance for certain siRNA sequence-specific patent applications

USPTO grants Micardia's patent concerning reshaping the anatomy of the heart

SIS files a patent aplication for a method of generating structured light for 3D image rendering

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News